Icosavax, Inc. Quarterly Operating Income (Loss) in USD from Q2 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Icosavax, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q3 2023.
  • Icosavax, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$25.3M, a 9.21% decline year-over-year.
  • Icosavax, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$106M, a 20.1% decline year-over-year.
  • Icosavax, Inc. annual Operating Income (Loss) for 2022 was -$95.1M, a 44.3% decline from 2021.
  • Icosavax, Inc. annual Operating Income (Loss) for 2021 was -$65.9M, a 252% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$106M -$25.3M -$2.13M -9.21% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$104M -$29M -$5.82M -25.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$97.9M -$26.5M -$2.87M -12.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 -$95.1M -$25.1M -$6.92M -38% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 -$88.1M -$23.1M +$11.3M +32.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$99.4M -$23.1M -$14.5M -169% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$84.9M -$23.7M -$19M -409% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$65.9M -$18.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$34.4M -$29M -531% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$8.59M -$3.39M -65% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$4.64M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 -$5.46M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$5.21M Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.